Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16th, 2018
Tag: LinearDNA
LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1st, 2018
LineaRx to Collaborate with Takis and Evvivax on Cancer Vaccines
September 20th, 2018
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20th, 2018
With New Spinoff, Biotech Goes All-In On DNA Sales
September 19th, 2018
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18th, 2018
APDN Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit
August 27th, 2018